Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)

Abstract The MITO-END3 trial compared carboplatin and paclitaxel (CP) with avelumab plus carboplatin and paclitaxel (CPA) as first-line treatment in endometrial cancer (EC) patients and demonstrated a significant interaction between avelumab response and mismatch repair status. To investigate progno...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	C. D’Alterio, G. Rea, M. Napolitano, E. Coppola, A. Spina, D. Russo, R. Azzaro, C. Mignogna, G. Scognamiglio, D. Califano, L. Arenare, C. Schettino, C. Pisano, S. C. Cecere, M. Di Napoli, A. Passarelli, F. Perrone, S. Pignata, S. Scala
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Springer 2025-04-01
Ráidu:	Cancer Immunology, Immunotherapy
Fáttát:	Endometrial cancer Chemotherapy Avelumab Myeloid-derived suppressor cells The Cancer Genome Atlas (TCGA)-based molecular classification
Liŋkkat:	https://doi.org/10.1007/s00262-025-04021-3
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!